Premature atherosclerosis in HIV positive patients and cumulated time of exposure to antiretroviral therapy (SHIVA study)
- 30 April 2006
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 185 (2) , 361-367
- https://doi.org/10.1016/j.atherosclerosis.2005.06.049
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV InfectionCirculation, 2004
- Colour-Doppler ultrasonography of carotid vessels in patients treated with antiretroviral therapyAIDS, 2004
- Combination Antiretroviral Therapy and the Risk of Myocardial InfarctionNew England Journal of Medicine, 2003
- Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD studyAIDS, 2003
- Factors Associated with Accelerated Atherosclerosis in HIV-1–Infected Persons Treated with Protease InhibitorsAIDS Patient Care and STDs, 2003
- Prediction of Coronary Heart Disease Risk in HIV‐Infected Patients with Fat RedistributionClinical Infectious Diseases, 2003
- Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitorsAtherosclerosis, 2002
- Exercise Stress Testing for Detection of Silent Myocardial Ischemia in Human Immunodeficiency Virus—Infected Patients Receiving Antiretroviral TherapyClinical Infectious Diseases, 2002
- Premature atherosclerosis in HIV-infected individuals – focus on protease inhibitor therapyAIDS, 2001
- Potent Inhibitory Effect of Troglitazone on Carotid Arterial Wall Thickness in Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 1998